Penserra Capital Management LLC Tekla Life Sciences Investors Transaction History
Penserra Capital Management LLC
- $7.17 Billion
- Q2 2025
A detailed history of Penserra Capital Management LLC transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Penserra Capital Management LLC holds 769,657 shares of HQL stock, worth $10.7 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
769,657
Previous 746,921
3.04%
Holding current value
$10.7 Million
Previous $9.48 Million
4.02%
% of portfolio
0.14%
Previous 0.17%
Shares
4 transactions
Others Institutions Holding HQL
# of Institutions
84Shares Held
9.41MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.02MShares$42 Million0.99% of portfolio
-
Morgan Stanley New York, NY766KShares$10.7 Million0.0% of portfolio
-
Royal Bank Of Canada Toronto, A6451KShares$6.29 Million0.0% of portfolio
-
Karpus Management, Inc. Pittsford, NY431KShares$6 Million0.23% of portfolio
-
Needham Investment Management LLC New York, NY392KShares$5.45 Million0.46% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...